SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-074804
Filing Date
2019-03-14
Accepted
2019-03-14 16:15:33
Documents
5
Period of Report
2019-03-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d719711d8k.htm 8-K 18894
2 EX-10.1 d719711dex101.htm EX-10.1 7903
3 EX-10.2 d719711dex102.htm EX-10.2 7892
4 EX-10.3 d719711dex103.htm EX-10.3 7919
5 EX-10.4 d719711dex104.htm EX-10.4 7724
  Complete submission text file 0001193125-19-074804.txt   51568
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35347 | Film No.: 19681252
SIC: 2834 Pharmaceutical Preparations